Mark A Glickman Neuro Bo Pharmaceuticals, Inc. (NRBO) insider trading activity

NRBO Quotes by TradingView

Mark A Glickman is Director of NeuroBo Pharmaceuticals, Inc.. Currently has a direct ownership of 37,887 shares of NRBO, which is worth approximately $61,755. The most recent transaction as insider was on Jun 30, 2025, when has been sold 28,147 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37.9K
288.98% 3M change
288.98% 12M change
Total Value Held $61,755

Mark A Glickman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2025
BUY
Grant, award, or other acquisition
-
28,147 Added 42.63%
37,887 Common Stock
Jun 07 2024
BUY
Grant, award, or other acquisition
-
5,051 Added 34.15%
9,740 Common Stock
Jul 27 2023
BUY
Grant, award, or other acquisition
-
37,500 Added 50.0%
37,500 Common Stock

Also insider at

TXMD
TherapeuticsMD, Inc. Healthcare
Co-Chief Executive Officer
MAG

Mark A Glickman

Director
Boca Raton, FL

Track Institutional and Insider Activities on NRBO

Follow NeuroBo Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRBO shares.

Notify only if

Insider Trading

Get notified when an Neuro Bo Pharmaceuticals, Inc. insider buys or sells NRBO shares.

Notify only if

News

Receive news related to NeuroBo Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NRBO